![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Risk of Parkinson's Disease in Hepatitis C Patients Following Exposure to Direct-Acting Antiviral Treatment: An Analysis of US Administrative Claims Data
|
|
|
AASLD: The Liver Meeting, October 20-24, 2017, Washington, DC
Reported by Jules Levin
L Telep, D Muramoto, A Osinusi, DM Brainard, AW Singer, AP Chokkalingam
Gilead Sciences, CA USA
![0610191](../../2019/images/061019/061019-2/0610191.gif)
![0610192](../../2019/images/061019/061019-2/0610192.gif)
![0610193](../../2019/images/061019/061019-2/0610193.gif)
![0610194](../../2019/images/061019/061019-2/0610194.gif)
![0610195](../../2019/images/061019/061019-2/0610195.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|